Separating samples with magbeads and more

Our bodies are extraordinarily complex, with intricate interactions between cells, nucleic acids, proteins, metabolites, and a whole range of other biomolecules. This complexity defines our individuality, and we can use it to our advantage in diagnostics. Leveraging modern techniques, samples can be analyzed to uncover endless aspects of our health, with the development of biomarker tests for organ function, diseases, pathogen infection, drug toxicity, and so much more.

With this in mind, the first hurdle in any diagnostic assay is to separate the target analyte from the rest of the sample components. Given the growing demand for speed, accuracy, and sensitivity in testing, a simple, yet precise separation solution is needed – this is where magnetic beads come into play. Magnetic beads are transforming diagnostics with their highly selective binding capabilities, speed, and versatility.

While magbeads have proven essential sample separation tools on their own, what if we could use them to elevate the performance of existing techniques, such as centrifugation or membrane separation? Instead of adopting an “either-or” approach, magbeads can be integrated with other methods to significantly enhance the performance of diagnostic assays.

In this article, we delve into how magnetic beads can be effectively paired with centrifugation and membrane separation to enhance assay sensitivity and efficiency. We explore how the synergy between magbeads and membranes is driving innovation in diagnostics. Additionally, we provide practical tips to help you get the most out of combining magbeads with other sample separation techniques.

Which sample preparation techniques can magbeads be combined with?

Using magbeads with centrifugation to isolate challenging cell types and biomarkers

Isolating certain cell types and extracellular vesicles (EVs), such as circulating tumor cells (CTCs) and exosomes, are notoriously difficult to isolate from samples, due to their low abundance and heterogeneity. However, CTCs and exosomes hold great power in diagnostics, containing an array of disease-specific biomarkers for cancer. A main benefit of these components is that they can be isolated from samples like urine, saliva, and plasma, offering a less invasive option than traditional tumor biopsies. Exosomes also provide biomarkers for other conditions including neurodegenerative diseases, eliminating the need for invasive brain biopsies and lumbar punctures (1).

Learn more on how exosomes are being used to identify and monitor disease

Traditionally , ultracentrifugation has been the go-to method for isolating exosomes and CTCs, specifically when dealing with larger sample volumes. However, this approach comes with several downsides, being labor-intensive, prone to contamination, and less effective for small sample volumes or rare vesicles.

Integrating magbeads with ultracentrifugation, can help improve purity issues and streamline sample separation steps. In these integrated workflows, a form of ultracentrifugation, termed “differential” centrifugation can be used with magnetic separation. This centrifugation technique separates cellular components based on their sedimentation rate, and is often used to remove large debris or pre-concentrate the sample. This technique can then be followed by magnetic separation to further purify the sample, enhancing the sensitivity of downstream diagnostic assays.

Several exosome and CTC-specific cell surface antigens such as CD63, CD81, and EpCAM for exosomes, and CD47 and EpCAM for CTCs have been identified (1,2). Developing functionalized magbeads that bind to these antigens means that CTCs and exosomes can be precisely separated using magnetic forces. So far, these magbeads have been integrated with centrifugation workflows to enhance exosome separation. This includes the isolation of tumor-derived exosomes for downstream assays to test for prostate cancer biomarkers (3).

Combining magbeads with membranes in lateral flow tests

Membranes are key players in diagnostics, particularly in point-of-care (POC) testing. Lateral flow tests (LFTs) are the most common type of POC test, booming in popularity following the COVID-19 pandemic. In LFTs, membranes play a key role not only in sample separation but also throughout the whole assay. They are responsible for capturing the reagents and detecting the target analyte. This makes the choice of membrane material critical for determining test sensitivity and speed.

Delve deeper into how membranes support POC diagnostics

A significant challenge in developing membrane-based POC tests is sample separation. Conventional methods used for isolating nucleic acids, proteins, and other biomolecules often involve complex equipment and several hands-on steps, which are not suitable for POC testing. To avoid this issue, samples can be directly added to the membrane pad. However, viscous samples like blood and plasma do not easily flow through membranes, resulting in an uneven sample flow that could impact the accuracy and reliability of your assays.

Magbeads offer a promising solution to enhance sample separation and analyte capture in membrane-based POC tests. These small but powerful tools can isolate nucleic acids, proteins, and other biomolecules directly from complex samples, requiring minimal processing. This makes magbeads highly suited for membrane-based POC tests. Incorporating magbeads to these POC tests addresses issues related to analyte concentration and background interference, allowing for the isolation of analytes with high sensitivity and specificity, even when dealing with complex samples.

Magbeads are widely used in lateral flow immunoassays. By purifying and concentrating the analyte before it is added to the lateral flow membrane, less sample is needed, and assay sensitivity can increase by up to 10-fold (4). Magbeads provide an effective and versatile option for POC immunoassays, with the capability to separate complex sample types. So far, bead-based lateral flow immunoassays have been widely used across diagnostics, with applications in disease biomarker testing, pathogen screening, toxin detection, drug monitoring, and more (5).

In addition to immunoassays, magbeads are increasingly being incorporated into more advanced molecular lateral flow assays. In these tests, magbeads provide a cleaner and more concentrated sample for nucleic acid amplification techniques, including Recombinase Polymerase Amplification (RPA), Polymerase Chain Reaction (PCR), Loop-mediated Isothermal Amplification (LAMP), and clustered regularly interspaced short palindromic repeats (CRISPR-Cas9 (6–8)). The amplified target DNA or RNA is then detected using lateral flow strips, with magbeads boosting sensitivity and specificity(8). You can find further insights into the role of membranes and magbeads in molecular lateral flow assays in our whitepaper.

Driving diagnostics forward with magbeads and membranes

Evidently, magbeads are elevating sample preparation steps across a wide range of diagnostic workflows, especially in membrane-based assays. Below, we explore how the combined use of magbeads and membranes is advancing diagnostics, including the development of multiplex immunoassays and lab-on-a-chip devices.

Multiplex lateral flow immunoassays

Magbeads are taking lateral flow immunoassays to the next level, thanks to their multiplexing capabilities. Beads conjugated to different disease-specific probes can be added to samples, to capture multiple analytes of interest. These magbead complexes are then added to the test sample pad to filter out any unwanted molecules, before being transported to the test lines containing the capture antibodies. This integrated workflow allows for the multiplex detection of various analytes, including neurotoxins, cardiac markers, and drugs, generating more powerful and higher throughput assays (9).

Creating lab-on-a-chip devices

Lab-on-a-chip devices are the latest generation of POC tests. These portable, compact assays are typically no more than a few centimeters wide, with microfluidic channels and reservoirs compartmentalizing all assay steps within a single device. Microfluidic devices are highly adaptable, capable of incorporating relatively simple diagnostic methods like fluorescence or chemiluminescence immunoassays, or more advanced techniques like surface-enhanced Raman spectroscopy (SERS), PCR, and LAMP(10,11). Miniaturizing these more advanced techniques into lab-on-a-chip devices is innovating diagnostics, offering fast turnaround and ultrasensitive detection.

In lab-on-a-chip devices, several different techniques can be used for sample separation. This includes separation via magbeads, membranes, electrophoresis, or immunoaffinity purification. Out of these options, magnetic separation is an ideal choice, with its high specificity, simplicity, and ease of integration. These techniques can also be more powerful when combined. For example, functionalized magbeads can isolate circulating tumor cells from whole blood samples, using the CD45 cell surface antigen. This is followed by membrane filtration to remove unwanted components, such as red blood cells. In this microfluidic device, integrating magbeads enhances the recovery of circulating tumor cells using membrane filtration alone, offering faster sample processing with fewer steps (12).

Some frequently asked questions to help you optimize magbead integration

Clearly, integrating magbeads into sample separation steps can bring many benefits to diagnostic assays. However, with huge diversity in the range of available magbeads, selecting the right bead for your unique requirements can be challenging. Here are some frequently asked questions to help guide you through the process of magbead selection and optimization.

Q: Which magbead size is right for my assays?

A: When it comes to magbeads, there is definitely no “one-size-fits-all” approach. Assay type is a key consideration for selecting the right bead size, with larger microbeads suiting workflows requiring centrifugation, while smaller beads (including nanoparticles) are more ideal for microfluidic systems.

Q: What bead coatings should I go for?

A: It goes without saying that you should choose surface chemistries that complement your target cells and analytes. In terms of bead coatings, streptavidin-coated beads are a good option for effective binding to biotinylated molecules, carboxylate-modified magbeads are versatile and can be used for nucleic acid capture as well as for binding various ligands through covalent coupling. Mag Sepharose beads are available with different coatings, such as streptavidin, protein A, NHS etc., each offering specific binding properties for different applications. For example, streptavidin Mag Sepharose beads are excellent for biotinylated molecules, protein A or G Mag Sepharose beads are ideal for binding antibodies, and NHS Mag Sepharose beads can be used for covalent coupling of a wide range of ligands.

Q: What considerations should I make for my sample volume?

A: Bead surface area, size, and binding capacity are key considerations for sample volume. When working with limited volumes, choosing beads with higher surface-to-volume ratio and binding capacity will ensure enough analyte is captured.

For larger sample volumes, larger beads with a lower surface-to-volume ratio can be used to enhance efficiency. Polymer-coated beads are ideal to reduce nonspecific binding when dealing with large and complex samples, and silica-based coatings also work well, offering high binding capacity without compromising on efficiency.

Q: How can I adapt my existing workflows to include magbeads?

A: Integrating new hybrid approaches into established workflows may introduce challenges, with the need to adjust various assay steps, like sample preparation, reagent mixing, and analyte detection. Partnering with suppliers, like Cytiva, can help ensure the smooth and seamless adaptation of your protocols, with the ability to pilot new workflows at a smaller scale before their full-scale adoption.

Need more help choosing the right magnetic beads for your assays? Read our all-encompassing guide.

Shaping the future of diagnostics with magbead integration

Magbeads are not only raising the potential of well-established sample separation tools like centrifugation and membranes, but they are also at the forefront of innovation, being key players in multiplex membrane-based and microfluidic devices. It’s an exciting time to be in the field, as we’re beginning to see the real-world impact of combining simple, yet effective tools like magbeads and membranes.

Tests are becoming faster, smaller, and more sensitive than ever, with the ability to isolate notoriously challenging biomarkers for complex conditions, including cancers and neurodegenerative diseases. In the not-so-far-away future, automation and high-throughput screening capabilities are set to elevate the bead and membrane-based assays to the next level. With further advances, we may even see devices that can automatically screen for hundreds of diseases within a single device.

At Cytiva, our aim is to help you excel in your diagnostic assays. Our customizable magbead chemistries, precision-engineered membranes, and innovative solutions empower you to push the boundaries of what’s possible in diagnostics.

Want to learn more on how our range of diagnostic solutions, including magbeads, membranes, and more can transform your diagnostic workflows? Request a consultation today.